Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by hcdtradingon Aug 31, 2019 1:02pm

210 Views

Post# 30086119

RE:RE:RE:RE:A good close for this week and month is

Okay here is the breakdown video explaining why being over .47 is important. Also I discuss the low volume and why Sirona should outsource a social media person to promote the brand. If they have the best skin lightener in a 22 billion a year business it would be good if more people know about that. They could hire a full time person from upwork for about 5-10$ an hour. As a share holder i would support that small expense.

Bullboard Posts

Changing Europe’s dependency on HREE from China